Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program

Vancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian-based company licensed by Health Canada to produce and supply natural, GMP-grade psilocybin and MDMA, has completed its largest production batch of MDMA to date-over 4,000 GMP capsules, enough to treat more than 1,000 patients.

As part of its commitment to ensuring long-term product stability and quality, Optimi has also completed one year of stability data on previously manufactured MDMA capsules, validating a one-year shelf life and extending the usability of its existing inventory for clinical and therapeutic applications. Additionally, the company has initiated a two-year stability program to further validate the long-term quality and reliability of its MDMA capsules.

With a growing number of authorized physicians prescribing Optimi's MDMA for PTSD in Australia, increasing demand for Special Access Program (SAP) requests in Canada, and a key Phase 2 clinical trial initiative for PTSD in Israel, Optimi is one of the few companies able to both manufacture its psychedelic drugs in-house and export cost-effective, GMP-grade MDMA capsules globally.

Highlights

"What we find most rewarding is that a portion of this latest batch will be directly used to treat patients in 2025 in Australia, where a growing number of authorized doctors are prescribing Optimi's MDMA for PTSD under the Authorized Prescriber Scheme," said Dane Stevens, CEO of Optimi Health.

"Additionally, our customer feedback is that our MDMA offering is often more cost-effective than other limited options in the market, making it an attractive solution for both patients and healthcare providers. We are excited to be producing affordable and stable inventory in-house under our Drug Establishment Licence. Combined with our capacity to store up to $50 million (CAD) worth of scheduled substances in our secure vault, Optimi is uniquely positioned to meet increased demand efficiently and reliably."

How to Access Optimi's MDMA Capsules

Entities interested in accessing Optimi's MDMA capsules can contact:Australia: Mind Medicine AustraliaGlobal Inquiries: sales@optimihealth.ca